Company intelligence / Profile preview

Hoffman Group

Basel, Switzerland

Ownership: Private
Employees: ~100000
Development stage: Other

Overview

Roche is a fully integrated commercial-stage multinational pharmaceutical and diagnostics company with a broad portfolio of marketed products across oncology, immunology, infectious diseases, ophthalmology, neuroscience, and other areas.

Modalities: Small moleculeMonoclonal antibodyBispecific T-cell Engager (BiTE)Bispecific antibodyEnzymeGene therapy
Industry: Pharma

Partnerships

Genentech (full ownership)Chugai Pharmaceuticals (majority ownership)Orionis Biosciences (2025 partnership for small-molecule protein degrader)Gilead Sciences (Tamiflu royalties)

Beyond the preview

Go deeper on Hoffman Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hoffman Group.

Explore the full profile